Properties
Description
Tofogliflozin is a sodium-glucose cotransporter inhibitor, preventing the kidneys from reabsorbing glucose.
Molecular Formula
C22H26O6
Identity
Confirmed by NMR/HPLC/MS.
Applications
Tofogliflozin is an SGLT2 inhibitor specifically studied for its role in glucose homeostasis and diabetes therapy.